Global Skin Grafting Market - Forecasts from 2017 to 2022
The Global Skin Grafting Market is projected to witness a compound annual growth rate of 12.29% during the forecast period to reach a total market size of US$6.825 billion by 2023, increasing from US$3.824 billion in 2018. The increasing numbers of burn injuries, skin infections, and ulcer pressure are leading to prolonged hospitalization and medical condition requiring immediate attention. The development of skin grafting techniques and technological advances in dermatomes are some of the factor boosting the global skin grafting market.
Geographically, North America is projected to continue to lead the global skin grafting market due to the high adoption rate of new technology and greater purchasing power relative to other regions. However, according to WHO, a majority of the burn cases are found in South East Asia region and thus this represents the untapped potential of the market.
Competitive Landscape
The Global Skin Grafting Market is competitive owing to them to the presence of well-diversified international, regional and local players. However, some big international players dominate the market share owing to their brand image and market reach. The high market growth and favorable government policies are further attracting more players in the market while enhancing the competitive rivalry. The competitive landscape details strategies, products, and investments being done by key players in different technologies and companies to boost their market presence.
Some of the major players discussed in the report are Organogenesis, Inc., Exsurco Medical, Inc., Mallinckrodt Pharmaceuticals, Tissue Regenix, Avita Medical among others.
Segmentation
The Global Skin Grafting Market has been segmented by graft type, graft thickness, application, equipment, end users, and geography.
By Graft Type
Autologous
Allogenic
Xenogenic
Prosthetic
By Graft Thickness
Slip Thickness
Full Thickness
Composite Graft
By Application
Extensive Wounds
Burns
Extensive skin loss due to infection
Skin Cancers
Others
By Equipment
Dermatome
General Surgical Instruments
Consumables
Others
By End Users
Hospitals and Clinics
Academic and Research
Others
By Geography
Americas
North America
South America
Europe Middle East and Africa
Europe
MEA
Asia Pacific
Geographically, North America is projected to continue to lead the global skin grafting market due to the high adoption rate of new technology and greater purchasing power relative to other regions. However, according to WHO, a majority of the burn cases are found in South East Asia region and thus this represents the untapped potential of the market.
Competitive Landscape
The Global Skin Grafting Market is competitive owing to them to the presence of well-diversified international, regional and local players. However, some big international players dominate the market share owing to their brand image and market reach. The high market growth and favorable government policies are further attracting more players in the market while enhancing the competitive rivalry. The competitive landscape details strategies, products, and investments being done by key players in different technologies and companies to boost their market presence.
Some of the major players discussed in the report are Organogenesis, Inc., Exsurco Medical, Inc., Mallinckrodt Pharmaceuticals, Tissue Regenix, Avita Medical among others.
Segmentation
The Global Skin Grafting Market has been segmented by graft type, graft thickness, application, equipment, end users, and geography.
By Graft Type
Autologous
Allogenic
Xenogenic
Prosthetic
By Graft Thickness
Slip Thickness
Full Thickness
Composite Graft
By Application
Extensive Wounds
Burns
Extensive skin loss due to infection
Skin Cancers
Others
By Equipment
Dermatome
General Surgical Instruments
Consumables
Others
By End Users
Hospitals and Clinics
Academic and Research
Others
By Geography
Americas
North America
South America
Europe Middle East and Africa
Europe
MEA
Asia Pacific
1. INTRODUCTION
1.1. Market Definition
1.2. Scope of the Study
1.3. Currency
1.4. Assumptions
1.5. Base, and Forecast Years Timeline
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Secondary Sources
2.3. Validation
3. KEY FINDINGS OF THE STUDY
4. MARKET DYNAMICS
4.1. Drivers
4.2. Restraints
4.3. Opportunities and Market Trends
4.4. Market Segmentation
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Industry Value Chain Analysis
4.7. Industry Regulations
4.8. Scenario Analysis
5. GLOBAL SKIN GRAFTING MARKET FORECAST BY TYPE (US$ BILLION)
5.1. Introduction
5.2. Autologous
5.3. Allogenic
5.4. Xenogenic
5.5. Prosthetic
6. GLOBAL SKIN GRAFTING MARKET FORECAST BY THICKNESS (US$ BILLION)
6.1. Introduction
6.2. Split Thickness
6.3. Full Thickness
6.4. Composite Graft
7. GLOBAL SKIN GRAFTING MARKET FORECAST BY APPLICATION (US$ BILLION)
7.1. Introduction
7.2. Extensive Wounds
7.3. Burns
7.4. Extensive Skin Loss Due To Infection
7.5. Skin Cancers
7.6. Others
8. GLOBAL SKIN GRAFTING MARKET FORECAST BY EQUIPMENT (US$ BILLION)
8.1. Introduction
8.2. Dermatome
8.3. General Surgical Instruments
8.4. Consumables
8.5. Others
9. GLOBAL SKIN GRAFTING MARKET FORECAST BY END USER (US$ BILLION)
9.1. Introduction
9.2. Hospital and Clinics
9.3. Academic and Research
9.4. Others
10. GLOBAL SKIN GRAFTING MARKET FORECAST BY GEOGRAPHY (US$ BILLION)
10.1. Introduction
10.2. Americas
10.2.1. North America
10.2.2. South America
10.3. Europe and MEA
10.3.1. Europe
10.3.2. Middle East And Africa (MEA)
10.4. Asia Pacific
11. COMPETITIVE INTELLIGENCE
11.1. Investment Analysis
11.2. Strategies of Key Players
11.3. Recent Investments And Deals
12. COMPANY PROFILES
12.1. Organogenesis Inc.
12.1.1. Overview
12.1.2. Financials
12.1.3. Product and Services
12.1.4. Key Developments
12.2. Exsurco Medical, Inc.
12.2.1. Overview
12.2.2. Financials
12.2.3. Products and Services
12.2.4. Key Developments
12.3. Mallinckrodt Pharmaceuticals
12.3.1. Overview
12.3.2. Financials
12.3.3. Products and Services
12.3.4. Key Developments
12.4. Tissue Regenix Group
12.4.1. Overview
12.4.2. Financials
12.4.3. Products and Services
12.4.4. Key Developments
12.5. Avita Medical
12.5.1. Overview
12.5.2. Financials
12.5.3. Products and Services
12.5.4. Key Developments
12.6. Zimmer Biomet
12.6.1. Overview
12.6.2. Financials
12.6.3. Products and Services
12.6.4. Key Developments
12.7. Aesculap, Inc
12.7.1. Overview
12.7.2. Financials
12.7.3. Products and Services
12.7.4. Key Developments
12.8. Nouvag AG
12.8.1. Overview
12.8.2. Financials
12.8.3. Products and Services
12.8.4. Key Developments
12.9. Surtex Instruments limited
12.9.1. Overview
12.9.2. Financials
12.9.3. Products and Services
12.9.4. Key Developments
1.1. Market Definition
1.2. Scope of the Study
1.3. Currency
1.4. Assumptions
1.5. Base, and Forecast Years Timeline
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Secondary Sources
2.3. Validation
3. KEY FINDINGS OF THE STUDY
4. MARKET DYNAMICS
4.1. Drivers
4.2. Restraints
4.3. Opportunities and Market Trends
4.4. Market Segmentation
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Industry Value Chain Analysis
4.7. Industry Regulations
4.8. Scenario Analysis
5. GLOBAL SKIN GRAFTING MARKET FORECAST BY TYPE (US$ BILLION)
5.1. Introduction
5.2. Autologous
5.3. Allogenic
5.4. Xenogenic
5.5. Prosthetic
6. GLOBAL SKIN GRAFTING MARKET FORECAST BY THICKNESS (US$ BILLION)
6.1. Introduction
6.2. Split Thickness
6.3. Full Thickness
6.4. Composite Graft
7. GLOBAL SKIN GRAFTING MARKET FORECAST BY APPLICATION (US$ BILLION)
7.1. Introduction
7.2. Extensive Wounds
7.3. Burns
7.4. Extensive Skin Loss Due To Infection
7.5. Skin Cancers
7.6. Others
8. GLOBAL SKIN GRAFTING MARKET FORECAST BY EQUIPMENT (US$ BILLION)
8.1. Introduction
8.2. Dermatome
8.3. General Surgical Instruments
8.4. Consumables
8.5. Others
9. GLOBAL SKIN GRAFTING MARKET FORECAST BY END USER (US$ BILLION)
9.1. Introduction
9.2. Hospital and Clinics
9.3. Academic and Research
9.4. Others
10. GLOBAL SKIN GRAFTING MARKET FORECAST BY GEOGRAPHY (US$ BILLION)
10.1. Introduction
10.2. Americas
10.2.1. North America
10.2.2. South America
10.3. Europe and MEA
10.3.1. Europe
10.3.2. Middle East And Africa (MEA)
10.4. Asia Pacific
11. COMPETITIVE INTELLIGENCE
11.1. Investment Analysis
11.2. Strategies of Key Players
11.3. Recent Investments And Deals
12. COMPANY PROFILES
12.1. Organogenesis Inc.
12.1.1. Overview
12.1.2. Financials
12.1.3. Product and Services
12.1.4. Key Developments
12.2. Exsurco Medical, Inc.
12.2.1. Overview
12.2.2. Financials
12.2.3. Products and Services
12.2.4. Key Developments
12.3. Mallinckrodt Pharmaceuticals
12.3.1. Overview
12.3.2. Financials
12.3.3. Products and Services
12.3.4. Key Developments
12.4. Tissue Regenix Group
12.4.1. Overview
12.4.2. Financials
12.4.3. Products and Services
12.4.4. Key Developments
12.5. Avita Medical
12.5.1. Overview
12.5.2. Financials
12.5.3. Products and Services
12.5.4. Key Developments
12.6. Zimmer Biomet
12.6.1. Overview
12.6.2. Financials
12.6.3. Products and Services
12.6.4. Key Developments
12.7. Aesculap, Inc
12.7.1. Overview
12.7.2. Financials
12.7.3. Products and Services
12.7.4. Key Developments
12.8. Nouvag AG
12.8.1. Overview
12.8.2. Financials
12.8.3. Products and Services
12.8.4. Key Developments
12.9. Surtex Instruments limited
12.9.1. Overview
12.9.2. Financials
12.9.3. Products and Services
12.9.4. Key Developments
